Demonetisation: Pune think tank advised Modi, suggested scrapping income tax too

ArthaKranti claims its leading light Anil Bokil, an Aurangabad-based chartered accountant and architect, was allocated nine minutes' audience with Modi in July this year
1479099920-5881
Pune-based economic think tank ArthaKranti, which claims to have suggested to Prime Minister Narendra Modi to demonetise the Rs 500 and Rs 1,000 currency notes, wants the government to abolish income tax and 56 other taxes and replace it by a banking transaction tax, or BTT, of two per cent on earnings.
“Imagine, taxes reduced. Petrol at Rs 28 per litre. That is ArthaKranti’s next proposal,” the outfit tweeted on Monday. ArthaKranti, which literally means financial or economic revolution, is a group of technocrats and chartered accountants. It first proposed its five-point proposal for tax reforms in 1999.
It had even planned a meeting in Pune on November 11-13 to demand that the PM implement its five-point agenda. According to the organisation, it has had regular interactions with officials in the Prime Minister’s Office all through 2015, and that it had given its blueprint for an economic revolution in the country to Modi in 2014, before he was elected the prime minister.
ArthaKranti claims its leading light Anil Bokil, an Aurangabad-based chartered accountant and architect, was allocated nine minutes’ audience with Modi in July this year, but the two discussed the idea of demonetisation for over 90 minutes. The group had also met Modi in Gandhinagar in 2013, when he was the chief minister of Gujarat. On Sunday, the PM said in Belgaum that the demonetisation move was planned by a small group of people over the past 10 months.
The outfit wants all taxes, including income tax, be done away with. The only current tax it says should be retained is import duty or Customs. Read More

Comments

Popular posts from this blog

The Flipkart-ebay deal and the high stake battle with Amazon

Amazon now has customers in 100% serviceable pin-codes in India: Jeff Bezos

Hypertension drug recall by USFDA shot in the arm for some drug majors